11/08/2024 Argaam Exclusive
Shares of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) hit an all-time high today, Aug. 11, at SAR 166.80.
The stock closed 1% lower at SAR 159.80 as about 230,000 shares changed hands.
| Year High (SAR) | Year Low (SAR) |
| 166.80 | 100.20 |
| Highest Since Debut (SAR) | Lowest Since Debut (SAR) |
| 166.80 | 66.00 |
| Open | 140.40 |
| Low | 139.30 |
| High | 141.90 |
| Previous Close | 140.40 |
| Change (3M) | (7.37 %) |
| Change (6M) | (11.11 %) |
| Market Value | 9,856.00 |
| Avg. Volume (3M) | 59,929.75 |
| Avg. Turnover (3M) | 9,252,919.03 |
| Avg. Transaction (3M) | 2,174.19 |
| Change(12M) | (11.00 %) |
| YTD | (7.49 %) |
Jamjoom Pharma has not amended its capital since listing on the Saudi Exchange (Tadawul) on June 20, 2023.
| Date | Type | Capital (M Riyal) | Change (%) |
| 2023 | IPO | 700.00 | 0.00% |
| Financial Ratio | Current |
| Market Cap (M Riyal) | 9,856.01 |
| Shares Outstanding ((M)) | 70.00 |
| EPS ( ) (TTM) | 6.39 |
| Book Value (BV) ( Riyal) (Latest announcement) | 23.61 |
| Recurring P/E | 22.03 |
| Price/book | 5.96 |
| Dividend Yield (%) (Last Year) | 2.17 |
| Return on Average Assets (%) (TTM) | 22.92 |
| Return on Average Equity (%) (TTM) | 28.89 |
| Par Value ( Riyal) | 10.00 |
| Enterprise Value (EV) (M Riyal) | 9,686.31 |
| EV/adj EBITDA | 19.56 |
| EV/Revenues | 6.65 |
Fair Average Price
Number of Recommendations
| Rating | Research firm | Current Price | Target Price | Change | |
| Buy | United Securities Company | 136.80 | 156.86 | 14.66 % |
Be the first to comment
Comments Analysis: